MNJ Institute of Oncology and Regional Cancer Centre

Hyderabaad 500004

0 studies enrolling now · 1 studies all time

What they study most

Ovarian Cancer

Studies at this site

• Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse — Stopped early